Cancer Letters
Volume 205, Issue 2 , Pages 181-188 , 18 March 2004

A survey of gene-specific methylation in human prostate cancer among black and white men

Received 27 July 2003 ,Revised 25 November 2003 ,Accepted 26 November 2003.

References 

  1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J. Clin. 1999;49:8–31
  2. Etzioni R, Penson DF, Legler JM, di Tommaso D, Boer R, Gann PH, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from US prostate cancer incidence trends. J. Natl Cancer Inst. 2002;94:981–990
  3. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002;3:415–428
  4. Brooks JD, Weinstein M, Lin X, Sun Y, Pin SS, Bova GS, et al.  CG island methylation changes near the GSTP1 gene in prostatic intraepithelial neoplasia. Cancer Epidemiol. Biomarkers Prev. 1998;7:531–536
  5. Lin X, Tascilar M, Lee WH, Vles WJ, Lee BH, Veeraswamy R, et al.  GSTP1 CpG island hypermethylation is responsible for the absence of GSTP1 expression in human prostate cancer cells. Am. J. Pathol. 2001;159:1815–1826
  6. Goessl C, Krause H, Muller M, Heicappell R, Schrader M, Sachsinger J, et al. Fluorescent methylation-specific polymerase chain reaction for DNA- based detection of prostate cancer in bodily fluids. Cancer Res. 2000;60:5941–5945
  7. Kuzmin I, Gillespie JW, Protopopov A, Geil L, Dreijerink K, Yang Y, et al.  The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res. 2002;62:3498–3502
  8. Maruyama R, Toyooka S, Toyooka KO, Harada K, Virmani AK, Zochbauer-Muller S, et al.  Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res. 2001;61:8659–8663
  9. Lou W, Krill D, Dhir R, Becich MJ, Dong JT, Frierson HF, et al.  Methylation of the CD44 metastasis suppressor gene in human prostate cancer. Cancer Res. 1999;59:2329–2331
  10. Nelson JB, Lee WH, Nguyen SH, Jarrard DF, Brooks JD, Magnuson SR, et al.  Methylation of the 5′ CpG island of the endothelin B receptor gene is common in human prostate cancer. Cancer Res. 1997;57:35–37
  11. Kito H, Suzuki H, Ichikawa T, Sekita N, Kamiya N, Akakura K, et al.  Hypermethylation of the CD44 gene is associated with progression and metastasis of human prostate cancer. Prostate. 2001;49:110–115
  12. Nakayama T, Watanabe M, Yamanaka M, Hirokawa Y, Suzuki H, Ito H, et al.  The role of epigenetic modifications in retinoic acid receptor beta2 gene expression in human prostate cancers. Lab Invest. 2001;81:1049–1057
  13. Woodson K, Hayes RB, Wideroff L, Villaruz L, Tangrea JT. Hypermethylation of GSTP1, CD44 and E-cadherin genes in prostate cancer among US. Blacks and Whites. Prostate. 2003;55:199–205
  14. Hayes RB, Ziegler RG, Gridley G, Swanson C, Greenberg RS, Swanson GM, et al.  Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol. Biomarkers Prev. 1999;9:25–34
  15. Li LC, Zhao H, Nakajima K, Oh BR, Filho LA, Carroll P, et al. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J. Urol. 2001;166:705–709
  16. Rennie PS, Nelson CC. Epigenetic mechanisms for progression of prostate cancer. Cancer Metastasis Rev. 1998;17:401–409
  17. Nelson JB, Carducci MA. The role of endothelin-1 and endothelin receptor antagonists in prostate cancer. B. J. U. Int. 2000;85:45–48
  18. Jeronimo C, Henrique R, Campos PF, Oliveira J, Caballero OL, Lopes C, et al. Endothelin B receptor gene hypermethylation in prostate adenocarcinoma. J. Clin. Pathol. 2003;56:52–55
  19. Chetcuti A, Margan SH, Russell P, Mann S, Millar DS, Clark SJ, et al.  Loss of annexin II heavy and light chains in prostate cancer and its precursors. Cancer Res. 2001;61:6331–6334
  20. Cui J, Rohr LR, Swanson G, Speights VO, Maxwell T, Brothman AR. Hypermethylation of the caveolin-1 gene promoter in prostate cancer. Prostate. 2001;46:249–256
  21. Goessl C, Muller M, Heicappell R, Krause H, Straub B, Schrader M, et al. DNA-based detection of prostate cancer in urine after prostatic massage. Urology. 2001;58:335–338

PII: S0304-3835(03)00819-X

doi: 10.1016/j.canlet.2003.11.027

Cancer Letters
Volume 205, Issue 2 , Pages 181-188 , 18 March 2004

Article Tools